Sterling Investment Advisors (Pennsylvania)’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-401
Closed -$42K 544
2022
Q2
$42K Hold
401
0.01% 240
2022
Q1
$51K Sell
401
-11
-3% -$1.33K 0.01% 251
2021
Q4
$51K Hold
412
0.01% 251
2021
Q3
$59K Sell
412
-258
-39% -$38K 0.02% 234
2021
Q2
$105K Hold
670
0.03% 196
2021
Q1
$104K Hold
670
0.03% 187
2020
Q4
$100K Hold
670
0.03% 177
2020
Q3
$88K Hold
670
0.03% 172
2020
Q2
$77K Hold
670
0.03% 180
2020
Q1
$65K Hold
670
0.03% 170
2019
Q4
$97K Hold
670
0.04% 154
2019
Q3
$89K Hold
670
0.05% 158
2019
Q2
$77K Hold
670
0.04% 170
2019
Q1
$83K Hold
670
0.04% 168
2018
Q4
$67K Hold
670
0.04% 171
2018
Q3
$85K Buy
670
+103
+18% +$12.2K 0.04% 168
2018
Q2
$61K Hold
567
0.04% 189
2018
Q1
$60K Sell
567
-154
-21% -$17.9K 0.04% 181
2017
Q4
$84K Hold
721
0.05% 153
2017
Q3
$82K Hold
721
0.05% 146
2017
Q2
$90K Hold
721
0.06% 140
2017
Q1
$85K Hold
721
0.06% 141
2016
Q4
$72K Buy
+721
New +$77.3K 0.06% 139

Other funds holding ZBH

Sterling Investment Advisors (Pennsylvania)'s ZBH Position: Q3 2022 in Review

Sterling Investment Advisors (Pennsylvania) sold out of Zimmer Biomet (ZBH) in Q3 2022, closing a stake of 401 shares — an estimated $42K sold.

Sterling Investment Advisors (Pennsylvania) first reported a position in ZBH in Q4 2016 and held it in 23 quarters. The position peaked at $105K in Q2 2021. 920 funds tracked by Wall St. Rank hold ZBH as of Q3 2022.

  • Sterling Investment Advisors (Pennsylvania) reported no remaining Zimmer Biomet position as of Q3 2022 after selling out during the quarter.
  • Sterling Investment Advisors (Pennsylvania) sold 401 Zimmer Biomet shares in Q3 2022, an estimated $42K.
  • Sterling Investment Advisors (Pennsylvania) first reported a position in Zimmer Biomet in Q4 2016 and held it in 23 quarters.
  • Sterling Investment Advisors (Pennsylvania)'s Zimmer Biomet position peaked at $105K in Q2 2021.
  • 920 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2022.

Based on Sterling Investment Advisors (Pennsylvania)'s 13F filing for Q3 2022, filed 3 Nov 2022.